Huan-Zhang Xie, Hai Lan, You-Li Pan, Jun Zou, Ze-Rong Wang, Lin-Li Li, Qi Huang, Hui Zhang and Sheng-Yong Yang Identification of Novel Anaplastic Lymphoma Kinase (ALK) Inhibitors Using a Common Feature Pharmacophore Model Derived from Known Ligands Crystallized with ALK Chemical Biology & Drug Design 81
In this study, the common features of three known ALK inhibitors that were crystallized with ALK have been identified for constructing a novel pharmacophore model. The established pharmacophore model Hypo1 had been carefully validated, and then compared with Hypo1′ that was built using a traditional ligand-based pharmacophore modeling method, which results further demonstrated the correctness of Hypo1. This pharmacophore model was adopted to screen in silico chemical databases for novel ALK inhibitors.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf